Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: Meta-analysis of cost-effectiveness studies

被引:0
作者
Pratama, Adikara Pagan [1 ,2 ]
Chen, Su-Feng [3 ]
Liao, Shih-Chieh [4 ]
Su, Wei-Chia [3 ,5 ]
Yu, Jian-Hong [3 ,6 ]
机构
[1] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan
[2] Univ Airlangga, Fac Med, Dept Publ Hlth & Prevent Med, Surabaya, Indonesia
[3] China Med Univ, Coll Dent, Sch Dent, 91 Xueshi Rd, Taichung 40402, Taiwan
[4] China Med Univ, Sch Med, Dept Radiol, Taichung, Taiwan
[5] Kaohsiung Chang Gung Mem Hosp, Dept Dent, Div Oral & Maxillofacial Surg, 100,Tzyou 1st Rd, Kaohsiung 80756, Taiwan
[6] China Med Univ Hosp, Dept Dent, Orthodont, Taichung, Taiwan
关键词
Meta-analysis; Oropharyngeal cancer; Incremental cost- effectiveness ratio; Incremental net benefit; HPV VACCINATION; UNITED-STATES; HEALTH; PREVENTION; IMPACT;
D O I
10.1016/j.jds.2024.05.032
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background/purpose: The incidence of human papillomavirus (HPV)-r elated oropharyngeal cancer (OPC) is increasing worldwide. HPV vaccines have shown efficacy in preventing diseases in both males and females. Therefore, there is a need to develop costeffective strategies for HPV vaccines to prevent HPV-related OPC. This meta-analysis aimed to evaluate cost-effectiveness using the global mean of incremental cost-effectiveness ratios compared to the willingness-to-pay threshold and incremental net benefits (INBs) of HPV vaccination strategies between boys' extension vaccine and girls only. These recommendations will be useful for countries that have not implemented universal HPV vaccines in national programs, such as Taiwan. Materials and methods: Studies evaluating the cost-effectiveness of HPV vaccination strategies in the prevention of OPC that included both sexes versus girls only were identified through the Cochrane Library, EMBASE, PubMed, ScienceDirect, and Web of Science databases on February 05, 2024, and a meta-analysis of pooled INBs was performed using a random effects model. The outcome was an effective measurement of the OPC burden. The results are represented in USD (2024). Results: Fifteen model analyses were included. All the studies were conducted in high-income countries. The global mean of incremental cost-effectiveness ratio was $39,553 (95% CI, $27,008-66,641) per quality-adjusted life years gained, which was below the global mean of the willingness-to-pay threshold of $65,473 (95% CI, $52,138-83,755). Pooled INBs of $9370 (95% CI, $5046-13,695; P < 0.001) favored the extended HPV in boys. Conclusion: HPV vaccination strategies that include boys are cost-effective compared to those with girls only in preventing OPC burden. By implementing a universal HPV vaccination program, countries can receive $9370 in additional monetary benefits per patient. Given its relevance to high-income countries, this study offers key insights that can aid policymakers in Taiwan.
引用
收藏
页码:2045 / 2056
页数:12
相关论文
共 52 条
  • [1] Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire
    Anderson, Scott
    Isaac, Andre
    Jeffery, Caroline C.
    Robinson, Joan L.
    Isaac, Daniela Migliarese
    Korownyk, Christina
    Biron, Vincent L.
    Seikaly, Hadi
    [J]. JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2017, 46
  • [2] Meta-analysis of economic evaluation studies: data harmonisation and methodological issues
    Bagepally, Bhavani Shankara
    Chaikledkaew, Usa
    Chaiyakunapruk, Nathorn
    Attia, John
    Thakkinstian, Ammarin
    [J]. BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [3] Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis
    Bresse, Xavier
    Goergen, Christoph
    Prager, Bernhard
    Joura, Elmar
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (02) : 269 - 281
  • [4] Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys
    Burger, Emily A.
    Sy, Stephen
    Nygard, Mari
    Kristiansen, Ivar S.
    Kim, Jane J.
    [J]. PLOS ONE, 2014, 9 (03):
  • [5] Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
    Chaturvedi, Anil K.
    Anderson, William F.
    Lortet-Tieulent, Joannie
    Curado, Maria Paula
    Ferlay, Jacques
    Franceschi, Silvia
    Rosenberg, Philip S.
    Bray, Freddie
    Gillison, Maura L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (36) : 4550 - 4559
  • [6] The cost-effectiveness of male HPV vaccination in the United States
    Chesson, Harrell W.
    Ekwueme, Donatus U.
    Saraiya, Mona
    Dunne, Eileen F.
    Markowitz, Lauri E.
    [J]. VACCINE, 2011, 29 (46) : 8443 - 8450
  • [7] Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma
    Colzani, Edoardo
    Johansen, Kari
    Johnson, Helen
    Celentano, Lucia Pastore
    [J]. EUROSURVEILLANCE, 2021, 26 (50)
  • [8] Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies
    Crespo, Carlos
    Monleon, Antonio
    Diaz, Walter
    Rios, Martin
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2014, 14
  • [9] Combining cost-effectiveness results into a single measurement: What is the value?: Authors response
    Dilokthornsakul, Piyameth
    Veettil, Sajesh K.
    Lan, Le My
    Thakkinstian, Ammarin
    Hutubessy, Raymond
    Lambach, Philipp
    Chaiyakunapruk, Nathorn
    [J]. ECLINICALMEDICINE, 2022, 51
  • [10] The Role of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma
    Ducatman, Barbara S.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (06) : 715 - 718